Moderna (MRNA) Stock Statistics & Valuation Metrics

Moderna has a market cap or net worth of $18.75B. The enterprise value is $17.99B.

Moderna has 396,786,250 shares outstanding. The number of shares has decreased by -2.65% in one year.

Moderna’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -29.70%.

The current PE Ratio of Moderna is ―. Moderna’s PEG ratio is 0.19.

In the last 12 months, Moderna had revenue of 1.94B and earned -2.82B in profits. Earnings per share was -7.26.

In the last 12 months, operating cash flow was -1.45B and capital expenditures -137.00M, giving a free cash flow of -1.58B billion.

Moderna pays an annual dividend of ―, resulting in a dividend yield of ―

Moderna upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).

Moderna as a current ratio of 3.29, with Debt / Equity ratio of 17.52%

In the past 12 months, Moderna has paid 54.00M in taxes.

Moderna EV to EBITDA ratio is -4.23, with an EV/FCF ratio of -5.23.

Moderna has $5.21B in cash and marketable securities with $1.30B in debt, giving a net cash position of $3.91B billion.

Gross margin is -13.89%, with operating margin of -158.13%, and net profit margin of -145.16%.

The average price target for Moderna is $44.40, which is 11.43% higher than the current price. The consensus rating is Hold